Episode Details
Back to Episodes
Pharmaceutical Executive Daily: September 3, 2025
Published 8 months, 2 weeks ago
Description
In today’s Pharmaceutical Executive Daily, we cover Pfizer’s response to political pressure over COVID-19 vaccine safety data, Cheryl Reicin’s outlook on future GLP-1 investment, and Novartis’ $5.2 billion acquisition of Argo Biopharmaceuticals.